Martin Kerschensteiner
Munich, BY 81377, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.
Journal: Science translational medicine
Published: August 26, 2026
Feasibility of short imaging protocols for [18F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophy.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 17, 2026
[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.
Journal: Annals of clinical and translational neurology
Published: February 14, 2026
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis.
Journal: Science translational medicine
Published: October 01, 2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.
Journal: EBioMedicine
Published: May 30, 2025
Hyperreflective Foci in the Inner Nuclear Layer: Proof-of-Concept for an Optical Coherence Tomography Derived Microglia-Related Marker in Multiple Sclerosis.
Journal: Annals of neurology
Published: May 05, 2025
[18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 01, 2025
T-B cell cooperation in ectopic lymphoid follicles propagates CNS autoimmunity.
Journal: Science immunology
Published: April 25, 2025
RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen-presenting cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 24, 2025
Last Updated: 09/26/2026